Hepatitis C in Poland in 2017 / Wirusowe zapalenie wątroby typu C (wzw C) w Polsce w 2017 roku

Journal Title: Przegląd Epidemiologiczny - Year 2019, Vol 73, Issue 2

Abstract

OBJECTIVE. The aim of this article was to analyze the epidemiological situation of HCV in Poland in 2017, based on data collected as part of epidemiological surveillance. MATERIAL AND METHODS. The analysis was carried out based on: 1) individual data collected as part of epidemiological interviews with persons diagnosed with HCV infection in 2017, 2) diagnosis rate from bulletins “Infectious diseases and poisonings in Poland” for the years 2011-2017 and 3) data about deaths due to hepatitis C from the Demographic Surveys and Labour Market Department of the Central Statistical Office. RESULTS. In 2017, the diagnosis rate of HCV infection stayed on high level: 10.44 per 100,000 (4010 cases were reported). Stabilization of hepatitis C epidemiological situation was observed in the following issues: 1) diagnosis rate reported in men and women remained at a similar level (10.55 vs. 10.33 per 100,000); 2) diagnosis rate still showed variation depending on the voivodship (from 4.09 to 18.48 per 100,000) and the location of residence (urban/rural, 12.7 vs. 7.0 per 100,000); 3) the percentage of hospitalization accompanying the new cases of HCV infection has shown downward trend (36% in 2017); 4) the decreasing hepatitis C mortality trend was continued (175 cases of death in 2017); 5) the most common possible transmission route were still medical procedures. In 2017, the outbreak of HCV infection in the Lubelskie was registered. (8 patients, 291 exposed persons, with whom computer tomography with a contrast from multi-dose packaging was conducted, using an automatic injection device). CONCLUSIONS. Epidemiological situation of hepatitis C since 2015 is stable. The role of medical care in the transmission of HCV infections in Poland is worrying.

Authors and Affiliations

Karolina ZAkrzewska, Małgorzata Stępień, Magdalena Rosińska

Keywords

Related Articles

Thiomersal-containing vaccines - a review of the current State of knowledge

Thiomersal is an organomercury compound known for its antiseptic and antifungal properties and used as an antibacterial agent in pharmaceutical products, including vaccines and other injectable biological products. In re...

Imported malaria caused by Plasmodium falciparum – case report / Zawleczona malaria wywołana przez Plasmodium falciparum – opis przypadku

INTRODUCTION: Malaria is caused by the Plasmodium spp. which are spread through Anopheles mosquitoes. Disease is not endemic in Poland currently but can be brought from other countries, mostly from Africa and Asia. The m...

Current views on the persistence of immunity following hepatitis B vaccination

This paper presents current views on the persistence of immunity following vaccination against hepatitis B. Very high effectiveness of hepatitis B vaccination has been reported in a number of studies worldwide. Standard...

Pertussis in Poland in 2016 / Krztusiec w Polsce w 2016 roku

INTRODUCTION: In Poland, the high incidence of pertussis has been maintained for 10 years – in 2016 it was 17,77 per 100,000 population and it was 38% more compared to the previous year. The high percentage of pertussis...

Babeszjoza u ludzi

Babesia to pasożytnicze pierwotniaki krwinek czerwonych przenoszone przez kleszcze. Zachorowania u ludzi wywołuje kilka spośród ponad stu dotychczas opisanych gatunków/genotypów Babesia, najczęściej są to: B. microti, B....

Download PDF file
  • EP ID EP655115
  • DOI 10.32394/pe.73.16
  • Views 79
  • Downloads 0

How To Cite

Karolina ZAkrzewska, Małgorzata Stępień, Magdalena Rosińska (2019). Hepatitis C in Poland in 2017 / Wirusowe zapalenie wątroby typu C (wzw C) w Polsce w 2017 roku. Przegląd Epidemiologiczny, 73(2), 167-178. https://europub.co.uk/articles/-A-655115